Drug Chatter -- Tracking biopharma stock chatter

Profile for Epizyme, Inc. (EPZM)

« Back to company index

EPZM Chatter Timeline

Stock Ticker for EPZM

Most Active Tweeters for EPZM

UserTweets
@AmericanBanking 11
@TickerReport 9
@dakotafinancial 8
@TheMarketsDaily 8
@ConsumerFeed 7

Recent Tweets for EPZM

ZolmaxNews @ZolmaxNews
Epizyme $EPZM Upgraded to Hold by ValuEngine https://t.co/dKVvdX4tGA
May 23rd 2018, 11:05pm
ThisLincolnian @ThisLincolnian
Epizyme $EPZM Upgraded to Hold by ValuEngine https://t.co/aGjubhKJ0v
May 23rd 2018, 11:05pm
dailypoliticaln @dailypoliticaln
Epizyme $EPZM Upgraded to Hold by ValuEngine https://t.co/oVBXBADDGp
May 23rd 2018, 11:05pm
zolile88 @zolile88
$EPZM missed it when it ramped up by $0.95 i so wanted to short it now regretting not making the move #DayTrading
May 23rd 2018, 11:05am
registrarjourn @registrarjourn
Epizyme $EPZM Upgraded to “Buy” by BidaskClub https://t.co/ja0S20QbOA
May 23rd 2018, 6:05am
TranscriptDaily @TranscriptDaily
Epizyme $EPZM Upgraded to “Buy” by BidaskClub https://t.co/2kEKShWP9y
May 23rd 2018, 5:05am
dakotafinancial @dakotafinancial
Epizyme $EPZM Stock Rating Reaffirmed by HC Wainwright https://t.co/9BS4mqdr6w
May 23rd 2018, 2:05am
TheMarketsDaily @TheMarketsDaily
Epizyme $EPZM Stock Rating Reaffirmed by HC Wainwright https://t.co/pgB7LG3u4u
May 23rd 2018, 2:05am
ThisLincolnian @ThisLincolnian
Investment Analysts’ Weekly Ratings Changes for Epizyme $EPZM https://t.co/wmRcn319HI
May 22nd 2018, 4:05pm
ZolmaxNews @ZolmaxNews
Investment Analysts’ Weekly Ratings Changes for Epizyme $EPZM https://t.co/ni2X8Gjdvl
May 22nd 2018, 4:05pm
AmericanBanking @AmericanBanking
Investment Analysts’ Weekly Ratings Changes for Epizyme $EPZM https://t.co/j0BnmldqMn #stocks
May 22nd 2018, 4:05pm
dakotafinancial @dakotafinancial
BidaskClub Upgrades Epizyme $EPZM to Buy https://t.co/voJCpmu4e0
May 22nd 2018, 7:05am
TheMarketsDaily @TheMarketsDaily
BidaskClub Upgrades Epizyme $EPZM to Buy https://t.co/jYWp4AgFqB
May 22nd 2018, 7:05am
registrarjourn @registrarjourn
Epizyme $EPZM Price Target Raised to $25.00 https://t.co/ma6bpWKDxy
May 22nd 2018, 6:05am
OlympiaReport @OlympiaReport
Epizyme $EPZM Receives Buy Rating from HC Wainwright https://t.co/rmssJzDSYt
May 22nd 2018, 4:05am
dispatchtribune @dispatchtribune
Epizyme $EPZM Receives Buy Rating from HC Wainwright https://t.co/am7unx20rO
May 22nd 2018, 4:05am
dailypoliticaln @dailypoliticaln
Epizyme $EPZM Price Target Raised to $25.00 https://t.co/6SkK4aSYiv
May 22nd 2018, 3:05am
dispatchtribune @dispatchtribune
Epizyme $EPZM Price Target Raised to $25.00 https://t.co/XozhYL2Bl0
May 22nd 2018, 3:05am
1MinuteStock @1MinuteStock
Not sure what to do with $EPZM? Explore our #fundamental pros and cons. https://t.co/SnV0TiROAR
May 21st 2018, 3:05pm
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $EPZM for you: 8.74% https://t.co/bijmPrqNlf
May 21st 2018, 2:05pm
confcalltran @confcalltran
Submission of Matters to a Vote of Security Holders https://t.co/LrFrol1Ddq $EPZM
May 21st 2018, 2:05pm
AmericanBanking @AmericanBanking
Epizyme $EPZM Stock Rating Reaffirmed by HC Wainwright https://t.co/8OJAaUCKQS #stocks
May 21st 2018, 11:05am
TickerReport @TickerReport
Epizyme $EPZM Given Buy Rating at HC Wainwright https://t.co/5mAH42PqKJ
May 21st 2018, 7:05am
dailypoliticaln @dailypoliticaln
Epizyme $EPZM Given Buy Rating at HC Wainwright https://t.co/kpKOfsa9Yc
May 21st 2018, 7:05am
ARatings @ARatings
H.C. Wainwright Gives a Buy Rating to Epizyme $EPZM https://t.co/DkHLJXCeUq
May 21st 2018, 7:05am
WatchlistN @WatchlistN
Epizyme $EPZM PT Raised to $25.00 at Wedbush https://t.co/TP4VEDUqct
May 21st 2018, 5:05am
WeekHerald @WeekHerald
Wedbush Increases Epizyme $EPZM Price Target to $25.00 https://t.co/CEQ7KDs0LN
May 20th 2018, 6:05am
ZolmaxNews @ZolmaxNews
Wedbush Increases Epizyme $EPZM Price Target to $25.00 https://t.co/TGafm3l5ne
May 20th 2018, 4:05am
TranscriptDaily @TranscriptDaily
Epizyme $EPZM Given New $25.00 Price Target at Wedbush https://t.co/5LZT5hUhV1
May 19th 2018, 12:05pm
WebMax49 @WebMax49
RT @StockTipRobot: Prepare for the #robot uprising and #ragetrade Epizyme $EPZM #StockAdvice
May 19th 2018, 3:05am
StockTipRobot @StockTipRobot
Prepare for the #robot uprising and #ragetrade Epizyme $EPZM #StockAdvice
May 19th 2018, 3:05am
NewsQuantified @NewsQuantified
$EPZM Clinical Data Conference Call - Slideshow, stock falls -1.75%, #Epizyme https://t.co/Ruq9os3dF5
May 18th 2018, 9:05pm
AmericanBanking @AmericanBanking
Epizyme $EPZM Price Target Raised to $25.00 at Wedbush https://t.co/T0cqO5ageS #stocks
May 18th 2018, 5:05pm
42Stocks @42Stocks
https://t.co/ts5smDuI02 $EPZM Epizyme notable market movement up 2.1% = $25.8 million gain. https://t.co/6hxiRloVNb
May 18th 2018, 12:05pm
tradnews_ @tradnews_
RT @AlertTrade: VOLUME RADAR ALERT: $EPZM EPIZYME INC ? TradeIdeas via https://t.co/VS8RO1bzXJ to Free Trading Room
May 18th 2018, 10:05am
AlertTrade @AlertTrade
VOLUME RADAR ALERT: $EPZM EPIZYME INC ? TradeIdeas via https://t.co/VS8RO1bzXJ to Free Trading Room
May 18th 2018, 10:05am
dakotafinancial @dakotafinancial
Epizyme $EPZM Price Target Increased to $25.00 by Analysts at Wedbush https://t.co/ALWvO1JL5p
May 18th 2018, 8:05am
TheMarketsDaily @TheMarketsDaily
Epizyme $EPZM Price Target Increased to $25.00 by Analysts at Wedbush https://t.co/SUt0Q1Ewy9
May 18th 2018, 8:05am
StanBiotechMan @StanBiotechMan
RT @AndyBiotech: #ASCO18 $EPZM another very underwhelming dataset 3% (2/61) ORR rather laughable in a biomarker enriched population Oh bt…
May 17th 2018, 2:05pm
theflynews @theflynews
Epizyme's tazemetostat still looks "approvable and attractive". Here's why: https://t.co/72rXA6siUY $EPZM
May 17th 2018, 1:05pm
Casey23601993 @Casey23601993
RT @theflynews: Jefferies Epizyme's tazemetostat still looks "approvable and attractive": https://t.co/72rXA6siUY $EPZM
May 17th 2018, 12:05pm
theflynews @theflynews
Jefferies Epizyme's tazemetostat still looks "approvable and attractive": https://t.co/72rXA6siUY $EPZM
May 17th 2018, 12:05pm
zbiotech @zbiotech
jefferies yeezus - $EPZM data 'looks solid'** **gazing into his bobbly-head eyes to induce trance state is required https://t.co/sHsP730TpF
May 17th 2018, 11:05am
edtaussig @edtaussig
RT @AndyBiotech: In comparison to $EPZM 3% ORR in a biomarker enriched population, $MRK Keytruda showed 19% ORR, 66% DCR in an all-comer p…
May 17th 2018, 10:05am
AndyBiotech @AndyBiotech
In comparison to $EPZM 3% ORR in a biomarker enriched population, $MRK Keytruda showed 19% ORR, 66% DCR in an all-… https://t.co/92JvXW42eL
May 17th 2018, 10:05am
AndyBiotech @AndyBiotech
#ASCO18 $EPZM another very underwhelming dataset 3% (2/61) ORR rather laughable in a biomarker enriched population… https://t.co/N20V83M3dm
May 17th 2018, 9:05am
stockelite @stockelite
$EPZM Epizyme to Present New Tazemetostat Data at the American Society of Clinical Oncology (ASCO) Annual Meeting a… https://t.co/ncoldJa7c9
May 17th 2018, 9:05am
GNWLive @GNWLive
Epizyme to Present New Tazemetostat Data at the American Society of Clinical Oncology (ASCO) Annual Meeting $EPZM https://t.co/njTCHRDTLZ
May 17th 2018, 9:05am
ConsumerFeed @ConsumerFeed
Zacks: Analysts Expect Epizyme $EPZM Will Announce Quarterly Sales of $3.10 Million https://t.co/V4F7bOi9j8
May 16th 2018, 6:05pm
TranscriptDaily @TranscriptDaily
-$0.53 EPS Expected for Epizyme $EPZM This Quarter https://t.co/FrpPkWU3zf
May 16th 2018, 6:05pm

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.